BC Innovations | May 14, 2015
Distillery Therapeutics

Therapeutics: Potassium channel Kv4.2 (KCND2)

Neurology INDICATION: Alzheimer's disease (AD) Mouse studies suggest inhibiting KCND2 degradation in the hippocampus could help treat AD. In a mouse model of AD, hippocampal neuron dendrite excitability was higher and levels of KCND2, which...
Items per page:
1 - 1 of 1